What is the Impact Factor of Current Drug Targets?

According to the latest Clarivate Journal Citation Reports (JCR), the Journal Impact Factor of Current Drug Targets is 3.50, ranking in quartile Q2 of Web of Science (SCIE).

Is Current Drug Targets indexed in Web of Science or Scopus?

Yes, Current Drug Targets is indexed in Web of Science (SCIE, Q2 quartile). Furthermore, in Scopus (SCImago), it holds an SJR rating of 0.726 (Q2) and an H-index of 129.

Who publishes Current Drug Targets and what is the Article Processing Charge (APC)?

Current Drug Targets is published by Bentham Science Publishers B.V.. The estimated Article Processing Charge (APC) is approximately $3,098 USD, subject to institutional waivers and corresponding author affiliations.

What is the ISO-4 abbreviation and acronym of Current Drug Targets?

The official ISO-4 abbreviation of Current Drug Targets is "CURR DRUG TARGETS". This standardized title abbreviation is used in citation lists conforming to IEEE, APA, Harvard, or Vancouver styles.

WoS SCIE Q2Scopus Q2SCImago #7,885Top JournalReview JournalHybrid

Current Drug Targets

Abbreviation (ISO):CURR DRUG TARGETS

•

Identifier (ISSN):1389-4501(Print)/1873-5592(Online)

•

Publisher:Bentham Science Publishers B.V.

Official Website Submission Portal Compare

Clarivate IF (2026)

3.5↑ +1

Journal Impact Factor

IF Trend↓

WoS Quartile

WoS SCIETop Tier

Clarivate WoS JCR

WoS Categories↓

JCR Release Date: 2026-06-17

Impact Factor Trend (2018–2026)

Clarivate IF trend for Current Drug Targets

WoS Q2

Annual Impact Factor Metric

Current (2026):3.5

Scopus SJR & RankScopus Q2

0.726

#7,885

SCImago Journal Rank citation prestige weighting

Scopus Year: 2025

H-Index (2025)

129

129 papers with at least that number of citations each

WoS: SCIE / JCRTop Tier

Self-Citation Rate0%

Safe Level (< 15%)Warning Level (> 20%)

Self-citation below 15% indicates strong scholarly independence.

Volume & Open AccessHybrid

134articles/year

3.77% Gold OA•3% Original Research

Aims & Scope

Current Drug Targets aims to cover the latest and most outstanding developments on the medicinal chemistry and pharmacology of molecular drug targets e.g. disease specific proteins, receptors, enzymes, genes. Current Drug Targets publishes guest edited thematic issues written by leaders in the field covering a range of current topics of drug targets. The journal also accepts for publication mini- & full-length review articles and drug clinical trial studies. As the discovery, identification, characterization and validation of novel human drug targets for drug discovery continues to grow; this journal is essential reading for all pharmaceutical scientists involved in drug discovery and development.

Topics Covered (Recognized by AI)

Biology93.5%Medicine90.7%Internal medicine76.1%Chemistry76%Genetics75.4%Biochemistry71.7%Pathology43.8%Psychology38%Immunology32.7%Gene32.1%Endocrinology30.2%Psychiatry29.9%Cell biology29.6%Pharmacology29.5%Physics28.5%Organic chemistry27.1%Bioinformatics26%Receptor23.4%Cancer research21.1%Disease21.1%Cancer20.8%

Primary Research Areas

Medicine Pharmacy

Official Website NLM PubMed Catalog Submission Portal SCImago Profile

0 calls

Special Issues

Calls for Papers

No active Calls for Papers found for this journal.

Expand

WoS Categories & Quartiles

Detailed JCR / JCI category rankings and quartile breakdown from Clarivate

Clarivate JCR & JCI

JCRSCIE2026

PHARMACOLOGY & PHARMACY

Rank134/356

IndexSCIE

JCISCIE2026

PHARMACOLOGY & PHARMACY

Rank266/356

IndexSCIE

Category	Index	Rank	Quartile
PHARMACOLOGY & PHARMACY	JCRSCIE	134/356	Q2
PHARMACOLOGY & PHARMACY	JCISCIE	266/356	Q3

Annual Historical Statistics & Publications

Track annual publication volume, total citations, and Impact Factor evolution

12 year

2026Latest

IF3.5

Articles / Year95

Total Citations32

2025

IF2.5

Articles / Year61

Total Citations161

2024

IF3

Articles / Year77

Total Citations708

2023

IF3.2

Articles / Year90

Total Citations618

2022

IF2.937

Articles / Year117

Total Citations961

Year	Impact Factor	Articles / Year	Total Citations
2026	3.5	95	32
2025	2.5	61	161
2024	3	77	708
2023	3.2	90	618
2022	2.937	117	961
2021	3.465	160	2,671
2020	2.632	172	3,298
2019	2.642	130	2,931
2018	3.112	176	5,050
2017	—	141	5,300
2016	—	259	6,678
2015	—	218	6,560

SCImago & Scopus Journal Intelligence

Global SCImago ranking, SJR prestige index, Scopus coverage, and societal policy impact

Rank #7,885Scopus Q2SCImago Profile

Scopus Coverage:2000-2026

•

Scopus Broad Areas:Biochemistry, Genetics and Molecular BiologyPharmacology, Toxicology and Pharmaceutics

Scopus Citation Rank (SJR)Q2

0.726

Weighted prestige citation metric per document indexed in the Scopus database.

Quartile: Scopus Q2

Citations / Doc (2 years)

3.49

Average citations received per document published in the 2-year window.

2-Year Citation Window

Estimated Publication Fee (APC)

$3,098 USD

Estimated Article Processing Charge for Open Access publication.

Estimated cost / article

Scopus 3-Year Publication & Citation Window

3-Year Citations973

3-Year Documents276

Citable Documents253

Aggregated from Scopus database across the 3-year SJR evaluation window.

Societal Impact & Inclusivity (SCImago)

Policy Citations (Overton)0

Citations in government and international policy documents

Female Author Rate40.0%

Percentage of female authors published in the journal

Real-world societal policy reach and author gender diversity tracked by SCImago.

Scopus Subject Categories

Clinical BiochemistryQ2

Drug DiscoveryQ2

PharmacologyQ2

Molecular MedicineQ3

Academic Metric Intelligence

Journal Metrics & Citation Visualizations

Total Cites vs Self-Cites

Evaluation of scholarly independence and citation reach

Total citations steady growth

Self-citation: 0%

Citations per Document

Citation metric windows across 2, 3, and 4 years

Cites / Doc (4 years)Cites / Doc (3 years)Cites / Doc (2 years)

Chinese Academy of Sciences (CAS) Classification

Major / minor zone classification and CAS Early Warning List history

Major Category (Broad Field):

4区 (Zone 4)Medicine

Minor Category (Specific Field):

4区PHARMACOLOGY & PHARMACY

CAS Early Warning List History:

Updated annually: 2020 – 2024

2020

Not warned

2021

Not warned

2022

Not warned

2023

Not warned

2024

Not warned

Academic Intelligence Overview & Context

ImpaQ Analysis

Current Drug Targets (abbr: CURR DRUG TARGETS, ISSN: 1389-4501) is a peer-reviewed international scholarly journal in the field of Medicine, published by Bentham Science Publishers B.V. in Netherlands since 2000. The periodical holds a Journal Impact Factor (JIF) of 3.50, ranking in quartile Q2 of Web of Science (SCIE), a Scopus SJR indicator of 0.726 (Q2), an H-index of 129.

The journal enforces rigorous peer evaluation with a publication frequency of Bimonthly, an annual output of approximately 134 scientific articles. In terms of accessibility and author fees, it operates under the Hybrid model with an estimated APC of $3,098 USD. It serves as a benchmark publication platform for academics, researchers, and doctoral candidates seeking global research visibility.